Difference in mass analysis using labeled lysines (DIMAL-K): a new, efficient proteomic quantification method applied to the analysis of astrocytic secretomes.
about
Prophylactic valproic acid treatment prevents schizophrenia-related behaviour in Disc1-L100P mutant micePACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons.Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretionIdentification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics.The ROP vesicle release factor is required in adult Drosophila glia for normal circadian behavior.Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity.GFAP expression as an indicator of disease severity in mouse models of Alexander disease.Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosisMass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretomeCombined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers.Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines.
P2860
Q28484428-F4A1E0F8-6C93-4AB3-A084-9D0A5F6D17D7Q33276406-DDF62A31-2E89-446C-A7D2-59106ECD03CCQ33835688-083F23D5-F4DF-403A-A628-0EDD1C3DB7AAQ33837120-4D1E9E1B-1F4F-4E96-B507-50CB225A6B2DQ35812989-585D4CCE-5232-4DD9-82A6-4CFB436D8A7FQ36162638-E202BF12-1218-49AC-BF92-14307114BD85Q36706156-81FE0E15-E014-409A-B4FF-CFFBCE2803A8Q36890607-9D9CA1B5-82FB-447E-8364-D193A536731BQ37155916-603B6B1D-E1BB-40D7-B6CE-E9385FCD96C0Q37727199-1D2FAAFE-837E-4247-ADDC-C66861ED0172Q37829411-73499F14-6F42-4514-A9B6-31A653A1D4BA
P2860
Difference in mass analysis using labeled lysines (DIMAL-K): a new, efficient proteomic quantification method applied to the analysis of astrocytic secretomes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Difference in mass analysis us ...... ysis of astrocytic secretomes.
@ast
Difference in mass analysis us ...... ysis of astrocytic secretomes.
@en
type
label
Difference in mass analysis us ...... ysis of astrocytic secretomes.
@ast
Difference in mass analysis us ...... ysis of astrocytic secretomes.
@en
prefLabel
Difference in mass analysis us ...... ysis of astrocytic secretomes.
@ast
Difference in mass analysis us ...... ysis of astrocytic secretomes.
@en
P2093
P2860
P1476
Difference in mass analysis us ...... ysis of astrocytic secretomes.
@en
P2093
Emmanuelle Demey
Eric Mauger
Joël Poncet
Nathalie Galéotti
Nicolas Delcourt
Patrick Jouin
Philippe Marin
P2860
P304
P356
10.1074/MCP.M500040-MCP200
P577
2005-05-18T00:00:00Z